To check for the markers in blood in patients with pemphigus vulgaris.
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Pemphigus vulgaris
- Registration Number
- CTRI/2017/12/010871
- Lead Sponsor
- IADVL Research grant
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Consented newly diagnosed pemphigus vulgaris patients of all age group and sex
Consented relapsed pemphigus vulgaris patients of all ages and sex
Healthy first degree relatives of diagnosed pemphigus vulgaris patients
Exclusion Criteria
Non consented patients
Patients in remission
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Salivary anti desmoglien levels corelate with that of serum anti desmoglien levels and also disease severity in patients <br/ ><br>With pemphigus vulgaris <br/ ><br>Timepoint: 3 Months <br/ ><br>
- Secondary Outcome Measures
Name Time Method Salivary anti desmoglien level estimation can be used as a non <br/ ><br>invasive alternative in predicting the course and severity Pemphigus Vulgaris. <br/ ><br>Timepoint: 3months